Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian B McDermott

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Journal of Virology|July 2, 2010
Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challengeMatthew R Reynolds, Andrea M Weiler, Shari M Piaskowski, et al.
Structure (London, England : 1993)|April 30, 2022
Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersiteCrystal Sao-Fong Cheung, Jason Gorman, Sarah F Andrews, et al.
The Journal of Clinical Investigation|June 4, 2014
Abnormal B cell memory subsets dominate HIV-specific responses in infected individualsLela Kardava, Susan Moir, Naisha Shah, et al.
Journal of Virology|March 10, 2017
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved ImmunogenicityGwo-Yu Chuang, Hui Geng, Marie Pancera, et al.
Science Translational Medicine|July 31, 2015
Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infectionTakuya Yamamoto, Rebecca M Lynch, Rajeev Gautam, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Antibody reactivity to SARS-CoV-2 is common in unexposed adults and infants under 6 monthsAbdelilah Majdoubi, Christina Michalski, Sarah E O'Connell, et al.
Immunity|March 2, 2024
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidaseJulia Lederhofer, Yaroslav Tsybovsky, Lam Nguyen, et al.
Immunity|February 5, 2025
Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350M Gordon Joyce, Wei Bu, Wei-Hung Chen, et al.
Journal of Virology|July 8, 2011
The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challengeMatthew R Reynolds, Jonah B Sacha, Andrea M Weiler, et al.
The Journal of Infectious Diseases|May 19, 2021
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn InfantsElizabeth J McFarland, Coleen K Cunningham, Petronella Muresan, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Journal of Virology|July 2, 2010
Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challengeMatthew R Reynolds, Andrea M Weiler, Shari M Piaskowski, et al.
Structure (London, England : 1993)|April 30, 2022
Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersiteCrystal Sao-Fong Cheung, Jason Gorman, Sarah F Andrews, et al.
The Journal of Clinical Investigation|June 4, 2014
Abnormal B cell memory subsets dominate HIV-specific responses in infected individualsLela Kardava, Susan Moir, Naisha Shah, et al.
Journal of Virology|March 10, 2017
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved ImmunogenicityGwo-Yu Chuang, Hui Geng, Marie Pancera, et al.
Science Translational Medicine|July 31, 2015
Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infectionTakuya Yamamoto, Rebecca M Lynch, Rajeev Gautam, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Antibody reactivity to SARS-CoV-2 is common in unexposed adults and infants under 6 monthsAbdelilah Majdoubi, Christina Michalski, Sarah E O'Connell, et al.
Immunity|March 2, 2024
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidaseJulia Lederhofer, Yaroslav Tsybovsky, Lam Nguyen, et al.
Immunity|February 5, 2025
Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350M Gordon Joyce, Wei Bu, Wei-Hung Chen, et al.
Journal of Virology|July 8, 2011
The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challengeMatthew R Reynolds, Jonah B Sacha, Andrea M Weiler, et al.
The Journal of Infectious Diseases|May 19, 2021
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn InfantsElizabeth J McFarland, Coleen K Cunningham, Petronella Muresan, et al.
Pageof 18